Підписатись
Pierre Ellul
Pierre Ellul
Невідома організація
Підтверджена електронна адреса в gov.mt
Назва
Посилання
Посилання
Рік
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
C Maaser, A Sturm, SR Vavricka, T Kucharzik, G Fiorino, V Annese, ...
Journal of Crohn's and Colitis 13 (2), 144-164K, 2019
15192019
ECCO guidelines on therapeutics in Crohn's disease: medical treatment
J Torres, S Bonovas, G Doherty, T Kucharzik, JP Gisbert, T Raine, ...
Journal of Crohn's and Colitis 14 (1), 4-22, 2020
14062020
ECCO guidelines on therapeutics in ulcerative colitis: medical treatment
T Raine, S Bonovas, J Burisch, T Kucharzik, M Adamina, V Annese, ...
Journal of Crohn's and Colitis 16 (1), 2-17, 2022
7362022
ECCO guidelines on therapeutics in Crohn’s disease: surgical treatment
M Adamina, S Bonovas, T Raine, A Spinelli, J Warusavitarne, A Armuzzi, ...
Journal of Crohn's and Colitis 14 (2), 155-168, 2020
5942020
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects
A Sturm, C Maaser, E Calabrese, V Annese, G Fiorino, T Kucharzik, ...
Journal of Crohn's and Colitis 13 (3), 273-284, 2019
3962019
ECCO guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease
T Kucharzik, P Ellul, T Greuter, JF Rahier, B Verstockt, C Abreu, ...
Journal of Crohn's and Colitis 15 (6), 879-913, 2021
3652021
European Crohn’s and Colitis Organisation [ECCO] and the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] ECCO-ESGAR Guideline for Diagnostic Assessment in …
C Maaser, A Sturm, SR Vavricka, T Kucharzik, G Fiorino, V Annese, ...
J Crohns Colitis 13 (2), 144-164, 2019
3082019
Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study
J Burisch, G Kiudelis, L Kupcinskas, HAL Kievit, KW Andersen, ...
Gut 68 (3), 423-433, 2019
2762019
The pathogenesis of extraintestinal manifestations: implications for IBD research, diagnosis, and therapy
CRH Hedin, SR Vavricka, AJ Stagg, A Schoepfer, T Raine, L Puig, ...
Journal of Crohn's and Colitis 13 (5), 541-554, 2019
2042019
ECCO guidelines on therapeutics in ulcerative colitis: surgical treatment
A Spinelli, S Bonovas, J Burisch, T Kucharzik, M Adamina, V Annese, ...
Journal of Crohn's and Colitis 16 (2), 179-189, 2022
1872022
Natural disease course of ulcerative colitis during the first five years of follow-up in a European population-based inception cohort—an Epi-IBD study
J Burisch, KH Katsanos, DK Christodoulou, L Barros, F Magro, ...
Journal of Crohn's and Colitis 13 (2), 198-208, 2019
1632019
Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response
L Katz, JP Gisbert, B Manoogian, K Lin, C Steenholdt, GJ Mantzaris, ...
Inflammatory bowel diseases 18 (11), 2026-2033, 2012
1602012
Association of genetic variants in NUDT15 with thiopurine-induced myelosuppression in patients with inflammatory bowel disease
GJ Walker, JW Harrison, GA Heap, MD Voskuil, V Andersen, ...
Jama 321 (8), 773-785, 2019
1592019
ECCO guidelines on inflammatory bowel disease and malignancies
H Gordon, L Biancone, G Fiorino, KH Katsanos, U Kopylov, E Al Sulais, ...
Journal of Crohn's and Colitis 17 (6), 827-854, 2023
1542023
Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study
J Burisch, H Vardi, D Schwartz, M Friger, G Kiudelis, J Kupčinskas, ...
The lancet Gastroenterology & hepatology 5 (5), 454-464, 2020
1372020
European Crohn’s and Colitis Organisation topical review on complementary medicine and psychotherapy in inflammatory bowel disease
J Torres, P Ellul, J Langhorst, A Mikocka-Walus, M Barreiro-de Acosta, ...
Journal of Crohn's and Colitis 13 (6), 673-685e, 2019
1352019
ECCO guidelines on extraintestinal manifestations in inflammatory bowel disease
H Gordon, J Burisch, P Ellul, K Karmiris, K Katsanos, M Allocca, G Bamias, ...
Journal of Crohn's and Colitis 18 (1), 1-37, 2024
1332024
The efficacy of shortening the dosing interval to once every six weeks in Crohn’s patients losing response to maintenance dose of infliximab
U Kopylov, GJ Mantzaris, KH Katsanos, C Reenaers, P Ellul, JF Rahier, ...
Alimentary pharmacology & therapeutics 33 (3), 349-357, 2011
1142011
Perioperative dietary therapy in inflammatory bowel disease
M Adamina, K Gerasimidis, R Sigall-Boneh, O Zmora, ...
Journal of Crohn's and Colitis 14 (4), 431-444, 2020
982020
European Crohn’s and Colitis Organisation topical review on environmental factors in IBD
C Maaser, E Langholz, H Gordon, J Burisch, P Ellul, VH Ramirez, ...
Journal of Crohn's and Colitis 11 (8), 905-920, 2017
962017
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20